Abstract | OBJECTIVE: PATIENTS AND METHODS: RESULTS: The levels of V-T, t-PTEF/t-E, MTIF/MTEF and TEF25/PTEF in both groups increased after treatment, but we observed a more significant improvement in the observation group. The CD4+ and CD4+/CD8+ levels in both groups also increased after the intervention, while the level of CD8+ decreased. The IL-10, IL-17 and TGF-β levels decreased more intensely in the observation group. DISCUSSION: The positive rate of lgG and lgM in both groups decreased significantly after the intervention. In the observation group, the asthma control rate was higher while the recurrence rate was lower. Although montelukast had little effect on improving the immune function, it was certainly beneficial for controlling the symptoms of asthma and improving the prognosis. CONCLUSIONS:
|
Authors | L Gong, L Xu, M Diao, F Guo, F-F Bian, J Min, R Liu, C-L Zhang |
Journal | European review for medical and pharmacological sciences
(Eur Rev Med Pharmacol Sci)
Vol. 20
Issue 24
Pg. 5256-5260
(12 2016)
ISSN: 2284-0729 [Electronic] Italy |
PMID | 28051240
(Publication Type: Journal Article)
|
Chemical References |
- Acetates
- Cyclopropanes
- Quinolines
- Sulfides
- Azithromycin
- montelukast
|
Topics |
- Acetates
(therapeutic use)
- Asthma
(drug therapy)
- Azithromycin
(therapeutic use)
- Child
- Cyclopropanes
- Humans
- Mycoplasma pneumoniae
- Pneumonia, Mycoplasma
(drug therapy)
- Quinolines
(therapeutic use)
- Sulfides
|